Lye Mun Tho - Department of Clinical Oncology, Beacon Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Asian Thoracic Oncology Research Group Expert Consensus Statement on the Peri-Operative Management of Non-Small Cell Lung Cancer

Stephanie P.L. Saw,Wen-Zhao Zhong, Rui Fu, Molly S.C. Li, Yasushi Goto, Stephen B. Fox,Yasushi Yatabe, Boon-Hean Ong, Calvin S.H. Ng, David D.W. Lee, Pham Cam Phuong, In Kyu Park,

Lung Cancerpp.108076, (2025)

引用0浏览0引用

Real-world Efficacy of Low Dose Osimertinib As Second-Line Treatment in Patients with Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer

Mau Ern Poh, Sivasubramaniam Balakrishnan, Sin Nee Tan,Muhammad Adil Zainal Abidin,Chong Kin Liam,Jiunn Liang Tan,Yong Kek Pang,Arvindran Alaga,Lye Mun Tho,Soon Hin How

TRANSLATIONAL LUNG CANCER RESEARCHno. 7 (2024): 1649-1659

引用0浏览0WOS引用

Tepotinib Plus Osimertinib in Patients with EGFR-mutated Non-Small-cell Lung Cancer with MET Amplification Following Progression on First-Line Osimertinib (INSIGHT 2): a Multicentre, Open-Label, Phase 2 Trial

Yi-Long Wu,Valentina Guarneri,Pei Jye Voon,Boon Khaw Lim,Jin-Ji Yang,Marie Wislez,Cheng Huang,Chong Kin Liam,Julien Mazieres,Lye Mun Tho,Hidetoshi Hayashi, Nguyen Viet Nhung,

LANCET ONCOLOGYno. 8 (2024): 989-1002

引用0浏览0WOS引用

Does Dose Reduction of Afatinib Affect Treatment Outcomes of Patients with EGFR-mutant Metastatic Non-Small Cell Lung Cancer in Real-World Clinical Practice

Mau Ern Poh,Chee Shee Chai,Chong Kin Liam,Gwo Fuang Ho,Yong Kek Pang,Harissa Husainy Hasbullah,Lye Mun Tho,Ibtisam Muhamad Nor,Kean Fatt Ho,Muthukkumaran Thiagarajan,Azlina Samsudin,Azza Omar,

TRANSLATIONAL LUNG CANCER RESEARCH（2024）

引用0浏览0WOS引用

Tepotinib + Osimertinib for EGFR Mutant (egfrm) NSCLC with MET Amplification (metamp) after First-Line (1L) Osimertinib

Daniel Shao-Weng Tan,Tae Min Kim,Valentina Guarneri,Pei Jye Voon,Boon Khaw Lim,Marie Wislez,Cheng Huang,Chong Kin Liam,Julien Mazieres,Lye Mun Tho,Hidetoshi Hayashi, Nguyen Nhung,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Abstract PR005: Tepotinib + Osimertinib in EGFR-mutant NSCLC with MET Amplification Following First-Line Osimertinib: INSIGHT 2 Primary Analysis

Xiuning Le,Tae Min Kim,Valentina Guarneri,Pei Jye Voon,Boon Khaw Lim,Jinji Yang,Marie Wislez,Cheng Huang,Chong Kim Liam,Julien Mazieres,Lye Mun Tho,Hidetoshi Hayashi,

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

引用0浏览0引用

Retrospective Analysis of Clinical Outcomes of Stereotactic Body Radiation Therapy for Localized Prostate Cancer at an Asian Cancer Specialist Centre

Jasmin Loh Pei Yuin, Jessica Tan Jia Shin, Chen Bao Jing,Tho Lye Mun,Manivannan Arkonam Balasubramaniam,Dato Mohamed Ibrahim Wahid

Asian Pacific Journal of Cancer Prevention（2023）

引用0浏览0WOS引用

Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country

Mau Ern Poh,Soon Hin How,Gwo Fuang Ho,Yong Kek Pang,Harissa H. Hasbullah,Lye Mun Tho,Ibtisam Muhamad Nor,Bee Chiu Lim,Kean Fatt Ho,Muthukkumaran Thiagarajan,Azlina Samsudin,Azza Omar,

CANCER MANAGEMENT AND RESEARCH（2023）

引用1浏览0WOS引用

Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia

Soon Hin How,Chong Kin Liam,Muhammad Adil Zainal Abidin,Harissa H. Hasbullah,Lye Mun Tho,Gwo Fuang Ho,Ibtisam Muhamad Nor, Yong Kek Pang, Kean Fatt Ho,Muthukkumaran Thiagarajan,Roziana Ariffin, Azlina Samsudin,

DOAJ (DOAJ Directory of Open Access Journals)（2022）

引用2浏览0WOS引用

Programmed Death‐ligand 1 Expression and Use of Immune Checkpoint Inhibitors among Patients with Advanced Non‐small‐cell Lung Cancer in a Resource‐limited Country

Soon Hin How,Lye Mun Tho,Chong Kin Liam,Harissa H. Hasbullah,Gwo Fuang Ho, Ibtisam Muhammad Nor,Mau Ern Poh,Kean Fatt Ho,Muthukkumaran Thiagarajan,Azlina Samsudin,Azza Omar,Choo Khoon Ong,

Thoracic Cancer（2022）

引用4浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn